Brookline Capital Management Predicts CervoMed Q2 Earnings
CervoMed Inc. (NASDAQ:CRVO – Free Report) – Research analysts at Brookline Capital Management issued their Q2 2025 earnings estimates for shares of CervoMed in a note issued to investors on Tuesday, March 11th. Brookline Capital Management analyst T. Bussian expects that the company will earn ($0.48) per share for the quarter. Brookline Capital Management has […]
